Cite

HARVARD Citation

    Couroux, P. et al. (2019). First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis. Pulmonary pharmacology & therapeutics. p. . [Online]. 
  
Back to record